Gilbert syndrome in patients with type 1 diabetes-Prevalence, glycemic control, and microalbuminuria
- 17 January 2017
- journal article
- Published by Hindawi Limited in Pediatric Diabetes
- Vol. 18 (8), 803-807
- https://doi.org/10.1111/pedi.12488
Abstract
Gilbert syndrome (GS) is a common hereditary condition, characterized by intermittent unconjugated hyperbilirubinemia. In adults with type 2 diabetes and GS, a markedly lower prevalence of nephropathy was documented, suggesting a beneficial effect of hyperbilirubinemia. We investigated the prevalence of GS among individuals with type 1 diabetes mellitus (T1DM), and the prevalence of microalbuminuria. The prevalence of GS was assessed in 401 (204 female) patients with T1DM, median age 21.0 years, (interquartile range [IQR], 15.7-27.9), median disease duration 10.8 years (IQR, 5.7-15.8); and was compared with GS prevalence in 181 children (control). The prevalence of microalbuminuria was assessed in patients with T1DM and GS (group I) and compared with that of patients with T1DM alone (group II), in a ratio of 1:2 matched by gender, age, and duration of diabetes. The prevalence of GS in TIDM patients was significantly higher than in the control group (10.7% vs 3.3% respectively, p = .004), with no gender difference. Patients with T1DM and GS had significantly lower HbA1c levels than did those with T1DM alone 7.3 ± 1.2 vs 7.9 ± 1.3% respectively (56 ± 13 vs 63 ± 14 mmol/mol), p = .02. The rate of microalbuminuria was 14.0% vs 11.0% for patients with T1DM and GS, compared with those with T1DM alone (p = .6). The occurrence of GS was 3-fold higher among individuals with T1DM than in a healthy control group. Despite better glycemic control, the rate of microalbuminuria was similar among young individuals with T1DM and GS, and those with T1DM alone, suggesting no protective value to elevated bilirubin.Keywords
This publication has 22 references indexed in Scilit:
- Genetics and Pediatric Unconjugated HyperbilirubinemiaThe Journal of Pediatrics, 2013
- The Role of Bilirubin in Diabetes, Metabolic Syndrome, and Cardiovascular DiseasesFrontiers in Pharmacology, 2012
- The Role of Oxidative Stress in the Pathogenesis of Diabetic Vascular ComplicationsDiabetes & Metabolism Journal, 2012
- EponymEuropean Journal of Pediatrics, 2011
- A study of the natural history of diabetic kidney disease (DKD)Nephrology Dialysis Transplantation, 2011
- Biliverdin protects against the deterioration of glucose tolerance in db/db miceDiabetologia, 2011
- Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidaseKidney International, 2010
- Bilirubin Is Negatively Associated With A1C Independently of Fasting Plasma Glucose, Age, Obesity, Inflammation, Hemoglobin, and Iron in Apparently Healthy Japanese Men and WomenDiabetes Care, 2010
- Bilirubin in clinical practice: a reviewLiver International, 2008
- Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment?Nephrology Dialysis Transplantation, 2000